SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-022892
Filing Date
2009-07-17
Accepted
2009-07-16 19:50:27
Documents
38
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 BIOGEN IDEC INC. b73482bie10vq.htm 10-Q 1106085
2 EX-3.1 SECOND AMENDED AND RESTATED BYLAWS, AS AMENDED. b73482biexv3w1.htm EX-3.1 157311
3 EX-10.1 CONSULTING AGREEMENT BETWEEN EIDETICA BIOPHARMA GMBH AND HANS PETER HASL b73482biexv10w1.htm EX-10.1 21993
4 EX-10.2 DIRECTOR AGREEMENT BETWEEN BIOGEN IDEC INTERNATIONAL B.V. AND HANS PETER b73482biexv10w2.htm EX-10.2 22271
5 EX-10.3 ANNUAL RETAINER SUMMARY FOR BOARD OF DIRECTORS b73482biexv10w3.htm EX-10.3 9752
6 EX-31.1 SECTION 302 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER b73482biexv31w1.htm EX-31.1 8056
7 EX-31.2 SECTION 302 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER b73482biexv31w2.htm EX-31.2 8338
8 EX-32.1 SECTION 906 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND THE CHIEF F b73482biexv32w1.htm EX-32.1 3802
  Complete submission text file 0000950123-09-022892.txt   3742670

Data Files

Seq Description Document Type Size
9 EX-101 INSTANCE DOCUMENT biib-20090630.xml EX-101.INS 775017
10 EX-101 SCHEMA DOCUMENT biib-20090630.xsd EX-101.SCH 18319
11 EX-101 CALCULATION LINKBASE DOCUMENT biib-20090630_cal.xml EX-101.CAL 43602
12 EX-101 LABELS LINKBASE DOCUMENT biib-20090630_lab.xml EX-101.LAB 156370
13 EX-101 PRESENTATION LINKBASE DOCUMENT biib-20090630_pre.xml EX-101.PRE 77486
14 EX-101 DEFINITION LINKBASE DOCUMENT biib-20090630_def.xml EX-101.DEF 9988
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
BIOGEN IDEC INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 09949047
SIC: 2836 Biological Products, (No Diagnostic Substances)